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Study objective: The purpose of this study was to elucidate the surgical and oncological outcomes after
laparoscopic surgery for endometrial cancer at our hospital.
Materials and methods: Surgical outcomes, complications rates, 2-year survival rates, and recurrence
rates were evaluated in 44 patients who underwent total laparoscopic hysterectomy (TLH) and 57
patients who underwent total abdominal hysterectomy (TAH) for endometrial cancer at our hospital
between August 2010 and November 2013.
Results: There was no signiﬁcant difference between the two groups with respect to age or body mass
index. More than 80% of patients in both groups had stage I cancer. In the TLH group, the histological
types were endometrioid adenocarcinoma in 42 of 44 patients, carcinosarcoma in one patient, and se-
rous adenocarcinoma in one patient. Operative times were signiﬁcantly longer in the TLH group, but
patients in this group had less intraoperative blood loss, shorter hospital stays, and reduced levels of
postoperative pain, compared to patients in the TAH group. There were four cases of postoperative
infection and one case of vessel injury in the TLH group. No patient in this group required blood
transfusion or conversion to open surgery. There were recurrences in two (4.7%) patients in the TLH
group (i.e., carcinosarcoma and serous adenocarcinoma) and in ﬁve (8.6%) patients in the TAH group.
Conclusion: Laparoscopic surgery is safe and feasible for patients with early-stage endometrial cancer.
However, patients with carcinosarcoma and other histologic types of endometrioid adenocarcinoma
require special attention because of the high risk of recurrence and poor prognosis.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In recent years, the incidence of endometrial cancer has been
increasing in Japan. In 1990, 3574 cases were reported; in 2000, the
number had increased to 5609 cases; and in 2011, 14,763 new cases
were reported.1 Surgery is the initial treatment in 95% of all new
cases. Radiation therapy or chemotherapy is recommended for
patients who are not surgical candidates because of advanced age,
comorbidities, or stage IVB cancer with peritoneal or distant
metastasis.2 The standard operating procedures for endometrialinterest to declare relevant to
s and Gynecology, Juntendo
, Tokyo 113-8421, Japan.
for Gynecologic Endoscopy and Minim
nses/by-nc-nd/4.0/).cancer are hysterectomy, bilateral salpingo-oophorectomy, and
lymphadenectomy. Thus, the main treatment option for patients
with endometrial cancer is surgery. However, laparoscopic surgery
for endometrial cancer was not covered by insurance in Japan until
March 2014; before that point, an open abdominal approach was
the standard technique.
In 2005, a randomized controlled trial reported the analysis of
survival after laparoscopy versus laparotomy in women with
endometrial cancer.3 In 2009, the results of three other random-
ized controlled trials were also reported.4e6 In 2010, the results of
two more randomized controlled trials were also reported.7,8 In all
trials, intraoperative bleeding was signiﬁcantly less and the length
of hospitalization was signiﬁcantly shorter in laparoscopic surgery
than in abdominal surgery. There was no difference in organ injury
or intraoperative complications. Postoperative complications such
as ileus were signiﬁcantly fewer in laparoscopic surgery. There was
no difference in the recurrence rate. However, no difference inally Invasive Therapy. Published by Elsevier Taiwan LLC. This is an open access article under
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majority of patients (77.5 to 93.2%) in all of the trials had endo-
metrioid adenocarcinomas, which have inherently lower recur-
rence rates among early-stage endometrial cancers.
Based on the results of these randomized controlled trials,
insurance coverage has been extended to laparoscopic surgery for
endometrial cancer since April 2014 in Japan. Therefore, the
number of cases in Japan is expected to rise in the future. However,
the number of cases in Japan is small; therefore, the complication
rates, surgical outcomes, and oncological outcomes after laparo-
scopic surgery for endometrial cancer are unknown. The surgical
outcomes, complications rates, 2-year survival rates, and recur-
rence were retrospectively evaluated for laparoscopic surgeries
performed for endometrial cancer at our hospital.
Materials and Methods
This study was approved by the in-hospital ethics committee.
Fifty-three laparoscopic surgeries for endometrial cancer were
performed from August 2010 to November 2013. Forty-four pa-
tients (i.e., the TLH group) had laparoscopic hysterectomy, bilateral
salpingo-oophorectomy, and pelvic lymphadenectomy, and nine
patients had laparoscopic hysterectomy and bilateral salpingo-
oophorectomy. The main eligibility criterion for laparoscopic
surgery for endometrial cancer at our hospital is International
Federation of Gynecology and Obstetrics (FIGO) 2008 stage IA
grades 1 and 2 endometrioid adenocarcinoma diagnosed by
endometrial aspiration or curettage before major surgery. Patients
who met the eligibility criteria were offered laparoscopic surgery.
Pelvic lymphadenectomy was recommended for all patients with
endometrioid adenocarcinoma; however, not all patients con-
sented. Pelvic magnetic resonance imaging (MRI) and positron
emission tomographyecomputed tomography were performed
preoperatively in all patients to check for muscle and cervical
invasion and lymph node or ovarian metastasis or other cancers. If
the MRI ﬁndings suggested stage IB disease, then TLH was contra-
indicated and we performed open surgery with pelvic lymphade-
nectomy. The exclusion criteria were patients who could not be
placed in a lithotomy position or patients who had a large uterine
ﬁbroid that would have been difﬁcult to remove from the vagina.
Patients who had other than FIGO stage IA disease and endome-
trioid adenocarcinoma grades 1 or 2 were treated by adjuvant
chemotherapy.
In the present study, surgical outcomes, complications, recur-
rence, death, length of hospitalization, pain score (based on the
visual analog scale), and hemoglobin level on postoperative Day 1,
C-reactive protein (CRP) on postoperative Day 3, and 2-year
survival rates between the TLH group and the 57 patients (i.e.,
the TAH group) in whom open abdominal surgery for endometrial
cancer (e.g., hysterectomy, bilateral salpingo-oophorectomy, and
pelvic lymphadenectomy) were compared during the same period.
Laparoscopic surgical technique
Laparoscopic surgery for endometrial cancer was performed,
as follows: intermittent pneumatic compression was applied to
the lower extremities to prevent thrombosis. Prophylactic anti-
biotics were administered before the beginning of the surgery.
After general anesthesia was induced, the patient was placed in
the lithotomy position with the operator standing on the left side
of the patient. After carbon dioxide insufﬂation of the abdomi-
nopelvic cavity, an 11-mm camera trocar was placed at the um-
bilical region, followed by the placement of bilateral 5-mm
trocars at 3 cm inside the right and left anterior superior iliac
spines, a 12-mm trocar at the left upper quadrant, and a 5-mmtrocar at the right upper quadrant. A 10-mm 30 laparoscope
was used. No uterine manipulator was used. After the laparo-
scopic survey of the abdominal cavity, peritoneal cytology or a
washing cytology was collected. After sealing both oviducts, the
round ligament was sealed and divided, and the broad ligament of
the uterus was opened. After identifying the ureter at the crossing
of the uterine artery, the uterine artery was skeletonized, ligated,
and divided. The infundibulopelvic ligament was ligated and
divided. The uterosacral ligament was sealed and divided. After
the preparation of the bladder off the vagina, the cardinal liga-
ment was sutured and ligated and divided. A Vagi-Pipe (Hakko
Medical, Nagano, Japan) was inserted to localize the vaginal vault,
and the vaginal wall was incised with an electric scalpel. The
uterus was placed in a EZ-Purse (Hakko Medical) and removed
through the vagina. The vaginal stump was washed with saline
and sutured. In patients who received pelvic lymphadenectomy,
both lateral umbilical ligaments were lifted toward the abdomen
to ensure a sufﬁcient ﬁeld of view. The right and left common
iliac, external and internal iliac, and obturator lymph nodes were
resected using sterile probe covers and removed. An absorbable
adhesion barrier (Gynecare Interceed; Ethicon, Somerville, NJ,
USA) was placed over the peritoneum. A drain was inserted
through the left port. All laparoscopic surgeries were performed
by a laparoscopist and gynecologic oncologist team. The same
team performed all laparoscopic surgeries that were included in
this study.
Statistical analysis
Statistical analysis was performed using GraphPad Prism,
version 6.0 for Windows (GraphPad Software, Inc., San Diego, CA,
USA). The Student t test was used to analyze the results. All
calculated p values were two-sided and p < 0.05 was considered
statistically signiﬁcant. The disease-free and overall survival rates
were calculated by the KaplaneMeiermethod. Differences between
survival curves were analyzed using the log-rank test and p < 0.05
was considered statistically signiﬁcant.
Results
Laparoscopic hysterectomy, bilateral salpingo-oophorectomy,
and lymphadenectomy were performed in 44 patients (i.e., the
TLH group), and laparoscopic hysterectomy and bilateral
salpingo-oophorectomy were performed in nine patients. Fifty-
seven patients (i.e., TAH group) received abdominal hysterec-
tomy, bilateral salpingo-oophorectomy, and lymphadenectomy
during the same period.
The median age of the TLH group was 56 years (range,
39e78 years), and the median body mass index (BMI) value was
23.0 kg/m2 (range, 17.2e37.3 kg/m2). The median age of the TAH
groupwas 56 years (range, 31e80 years), and themedian BMI of the
TAH group was 22.5 kg/m2 (range, 16.9e40.5 kg/m2). Therefore, no
differences were observed between the TLH and TAH groups
(Table 1). In the TLH group, the postoperative histological diagnosis
for all patients was endometrioid adenocarcinoma, except for one
patient with carcinosarcoma and one patient with serous adeno-
carcinoma. Eighty-ﬁve percent or more of both groups had FIGO
stage I cancer. Patients with other than FIGO stage IA disease or
endometrioid adenocarcinoma grades 1 or 2 were treated with
chemotherapy. Nine (20.5%) patients in the TLH group and 18
(31.6%) patients in the TAH group also received chemotherapy (i.e.,
paclitaxel þ carboplatin, or paclitaxel þ epirubicin þ carboplatin).
The TLH group had signiﬁcantly longer operative times than the
TAH group (310.1 ± 67.1 minutes vs. 237.1 ± 67.6 minutes, p < 0.05;
Table 2). However, the TLH group had signiﬁcantly less
Table 1
Characteristics of patients with endometrial cancer by type of surgery.
Laparoscopy (n ¼ 44) Laparotomy (n ¼ 57) p
Age (y), median (range) 56 (39e78) 56 (31e80) N.S.
BMI kg/m2 median (range) 23.0 (17.2e37.3) 22.5 (16.9e40.5) N.S.
Histological subtype before surgery
Endometrioid adenocarcinoma grade 1 41 46
Endomertioid adenocarcinoma grade 2 3 11
Histological subtype
Endomertioid adenocarcinoma grade 1 39 42
Endomertioid adenocarcinoma grade 2 3 13
Endomertioid adenocarcinoma grade 3 0 2
Carcinosarcoma 1 0
Serous adenocarcinoma 1 0
FIGO (2008) stage
IA 35 39
IB 4 10
II 2 3
IIIA 1 5
IIIC1 1 0
IVB 1 0
Adjuvant chemotherapy
TC therapy 7 13
TEC therapy 2 5
BMI ¼ Body mass index; N.S. ¼ not signiﬁcant; TC ¼ paclitaxel þ carboplatin; TEC ¼ paclitaxel þ epirubicin þ carboplatin.
Table 2
Surgical outcome of patients with endometrial cancer by type of surgery.
Laparoscopy (n ¼ 44) Laparotomy (n ¼ 57) p
Duration of operation (min) 310.1 ± 67.1 237.1 ± 67.6 < 0.05
Estimated blood loss (mL) 100.3 ± 128.1 474.5 ± 362.0 < 0.05
Specimen (g) 162.5 ± 102.7 172.4 ± 124.0 N.S.
Lymph nodes yield 25.3 ± 8.3 23.9 ± 9.4 N.S.
Hospital stay (d) 7.9 ± 4.0 17.2 ± 6.9 < 0.05
Delta Hb (g/dL)a 1.8 ± 1.1 2.7 ± 1.0 < 0.05
Day 1 VAS 2.9 ± 1.2 4.0 ± 2.3 < 0.05
Day 3 CRP (mg/dL) 4.1 ± 3.1 4.9 ± 3.4 N.S.
Data are presented as mean ± the standard deviation.
CRP ¼ C-reactive protein; Hb ¼ hemoglobin; N.S. ¼ not signiﬁcant; VAS ¼ visual analog scale.
a Delta Hb ¼ (preoperation hemoglobin level) e (hemoglobin level on postoperation Day 1).
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p < 0.05), a smaller postoperative change in the hemoglobin level
(1.8 ± 1.1 g/dL vs. 2.7 ± 1.0 g/dL, p < 0.05), shorter hospital stays
(7.9 ± 4.0 days vs. 17.2 ± 6.9 days, p < 0.05), and a lower level of
postoperative pain (visual analog scale score, 2.9 ± 1.2 vs. 4.0 ± 2.3,
p < 0.05; Table 2). No signiﬁcant differences existed between the
two groups in specimen weight and number of lymph nodes and
CRP level on postoperative Day 3 (Table 2).
The overall rate of perioperative complications for all patients
was 13.9%. The rate of complications in the TLH group was 15.9%.
The complications in the TLH group were one case of vascular
injury, two cases of vaginal lacerations, and four cases of post-
operative infections. There were no cases of blood transfusion or
conversion to open abdominal surgery (Table 3).Table 3
Intra- and postoperative complications by type of surgery.
Laparoscopy (n ¼ 44) Laparotomy (n ¼ 57)
Bowel injury 0 0
Urinary injury 0 0
Vessel injury 1 0
Blood transfusion 0 3
Conversion 0 e
Vaginal cuff abscess 4 2
Vaginal wall laceration 2 0
Wound dehiscence 0 2The annual changes in the operative times and the blood loss in
the TLH group at our hospital from 2011 to 2013were indicated. The
operative times in 2013 was signiﬁcantly shortened, compared to
that in 2011 (Figure 1A). The blood loss in 2013was not signiﬁcantly
different from that in 2011 (Figure 1B).
Two (4.5%) patients in the TLH group and ﬁve (8.8%) patients in
the TAH group had a recurrence. The histopathology of the two
patients in the TLH group was carcinosarcoma and serous adeno-
carcinoma. Both patients received adjuvant chemotherapy, but
neither patient survived (Table 4).
The disease-free survival (p ¼ 0.317) and overall survival
(p¼ 0.941) were not statistically signiﬁcant between the TLH group
and TAH group (Figure 2).Discussion
Laparoscopic surgery is safe and feasible for patients with early-
stage endometrial cancer. However, patients with carcinosarcoma
and other histologic types of endometrioid adenocarcinoma require
special attention because of the high risk of recurrence and poor
prognosis.
It was the ﬁrst report of laparoscopic surgery for gynecological
cancer that Nezhat et al9 performed pelvic lymphadenectomy for
locally advanced cervical cancer in 1989. Childers and Surwit10 ﬁrst
reported laparoscopic surgery for endometrial cancer in 1992. Since
that time, many studies have reported the efﬁcacy of laparoscopic
Figure 1. Annual changes in (A) the duration of surgery and (B) the amount of blood loss in the laparoscopic group. The duration of surgery in 2012 and 2013 was signiﬁcantly
shorter than in 2011. The amount of blood loss is not signiﬁcantly different for each year.
Table 4
Recurrence and mortality cases in the laparoscopic group.
Patient Age (y) Pathology Stage pTNM Adjuvant therapy Site of recurrence DFS (mo) OS (mo)
1 62 Carcinosarcoma IA pT1aN0M0 (Peritoneal cytology positive) TC (5 courses) Pelvic 11 19
2 70 Serous adenocarcinoma IVB pT1aN0M1 (Peritoneal cytology positive) TEC (2 courses) Lung ascites 2 5
DFS ¼ disease-free survival; OS ¼ overall survival; TC ¼ paclitaxel þ carboplatin; TEC ¼ paclitaxel þ epirubicin þ carboplatin.
Figure 2. (A) The disease-free survival rate and (B) the overall survival rate show no statistically signiﬁcant difference between laparoscopy and laparotomy.
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scale randomizedcontrolled trial that compared1682patients in the
laparoscopic group with 920 patients in the open abdominal group
with early-stage endometrial cancer. There was no signiﬁcant dif-
ference in the intraoperative complication rates between the two
groups (10% in the laparoscopic group vs. 8% in the open group). The
laparoscopic group had a signiﬁcantly lower rate of postoperative
complications than the open group (14% vs. 21%) and a signiﬁcantly
reduced length of hospital stay. These results proved the safety of
laparoscopic surgery for endometrial cancer.
A prognostic analysis was also reported in 2012, and the ex-
pected 5-year survival rate was 89.9%.11 Lu et al12 also prospectively
compared 151 cases of laparoscopic surgery for endometrial cancer
with 121 cases of open abdominal surgery. They found that the rate
of postoperative complications was signiﬁcantly lower in the
laparoscopic group (12%) than in the open group, whereas the
recurrence rate (4.6%) and the 5-year survival rate (95%) was
comparable to that of the open group. In our study, the rates of
complication, recurrence, and 2-year survival were 15.9%, 4.5%, and
96.4%, respectively, which are in agreement with the ﬁndings of
previous studies.11 The number of resected lymph nodes was not
different between groups in the present study, and the degree ofcompletion was considered equivalent. A long-term convalescence
survey will be required in the future.
All patients in our study had postoperative histological
diagnoses of endometrioid adenocarcinoma grades 1 and 2, except
for two patients (who had serous adenocarcinoma and carcino-
sarcoma) in the TLH group. The suitability of laparoscopic surgery
for advanced endometrial cancer, other histologic types of endo-
metrioid carcinoma, carcinosarcoma, or sarcoma has not been
determined. It has been reported that the overall diagnostic accu-
racy of preoperative endometrial curettage was 35e96%, and the
overall diagnostic accuracy of endometrioid adenocarcinoma grade
3, serous adenocarcinoma, and clear cell adenocarcinoma was
45e74%.13e16 The cases of carcinosarcoma in this study were
identiﬁed as adenocarcinoma in the preoperative diagnosis. How-
ever, the sarcomatous component could not be determined. The
case of serous adenocarcinoma was endometrioid adenocarcinoma
grade 1 in the preoperative diagnosis. Assessing the tumor grade by
intraoperative frozen section may be useful.14,17 If another histo-
logic type of endometrioid adenocarcinoma or carcinosarcoma was
diagnosed after laparoscopic surgery, an additional treatment may
have been needed, based on the stage of advancement, and a strict
follow-up observation would have been necessary.
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than the TAH group. It has been signiﬁcantly shortened on an
annual basis since we began performing laparoscopic surgery for
patients with endometrial cancer. There has not been a notable
decrease in blood loss over subsequent years; however, one patient
in 2012 had a blood loss of 838 g on account of severe adhesions
accompanying endometriosis in combination with a vaginal wall
laceration. There has not been a signiﬁcant change, compared to the
early experience, although there was a trend toward decreased
blood loss by 2013. It is estimated that the improvement in skill
becomes apparent after a surgeon performs ~10 laparoscopic sur-
geries for uterine cancer, as reﬂected by reduced operative times,
blood loss, complication rates, and rates of conversion to open
abdominal surgery.18 The results of the present study support this
ﬁnding.
One case of vascular injury and two (4.5%) cases of vaginal wall
lacerations were the intraoperative complications and four (9.1%)
cases of infections were the postoperative complications in the TLH
group. These numbers are lower than those reported in the LAP2
study. The vascular injury was an injury to the left external iliac
vein during lymphadenectomy. Hemostasis was achieved by
applying pressure with a piece of gauze. All infections were vaginal
cuff abscesses that resolved with antibiotic treatment. The rate of
conversion to open abdominal surgery in the LAP2 study was very
high at 25%. Advanced age, high BMI, and metastatic lesions were
risk factors for conversion in the LAP2 study, and BMIwas listed as a
risk factor in the Life After Cancer Epidemiology (LACE) study.19 In
our study, the BMI tended to be lower than that in other re-
ports.3,4,6,7,11 Insufﬁcient visual ﬁeld, spreading of tumor cells,
bleeding, and technical issues were also listed as direct causes of
conversions to open abdominal surgery in the LAP2 study.
Laparoscopic surgery is a surgical procedure that can only be
safely performed with sufﬁcient technical skills. Laparoscopic sur-
gery for endometrial cancer requires technical skills and anatomical
knowledge. Because there are many obese patients, there is the risk
of conversion to open abdominal surgery. Therefore, it is a rule that
laparoscopists and gynecologic oncologists perform this operation
in our hospital. We have been able to perform the surgery with
lower rates of complications and conversion to open abdominal
surgery. We recommend this system to facilitate a safe completion.
We found no difference in the recurrence rates between the
laparoscopic group and the open abdominal group in our study.
Despite the longer operative times, the beneﬁts of reduced blood
loss, postoperative pain, and length of hospital stay conﬁrm that
laparoscopic surgery for early-stage endometrial cancer is a pro-
cedure that can be safely performed in Japan and can contribute to
improved quality of life for patients. However, the two deaths in the
TLH group because of recurrent cancers emphasize the need for
caution in patients with carcinosarcoma and other histologic types
of endometrioid adenocarcinoma. Recurrences at the port sites and
the vaginal stump can be attributed to laparoscopic surgery;
therefore, both oviducts should be sealed immediately on starting
the surgery, use of a uterine manipulator should be avoided, and
specimen bags should be used to remove the uterus and lymph
nodes to prevent intraperitoneal seeding of cancer cells.
We performed conventional multiport laparoscopic surgery in
this study, Natural oriﬁce transvaginal endoscopic surgery20 or
laparoendoscopic single site surgery21 are other minimally invasivemethods that may be safe and effective for select patients with
endometrial carcinoma.
This study was not a randomized controlled trial. However, our
results validate those of previous randomized controlled trials that
have shown that laparoscopic surgery for early-stage endometrial
cancer is a safe and feasible alternative.
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